Skip to main content
HLB Therapeutics Co.,Ltd. logo

HLB Therapeutics Co.,Ltd. — Investor Relations & Filings

Ticker · 115450 ISIN · KR7115450009 KO Manufacturing
Open in API
Filings indexed 445 across all filing types
Latest filing 2023-02-06 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 115450

About HLB Therapeutics Co.,Ltd.

https://hlbtherapeutics.co.kr/en/

HLB Therapeutics Co., Ltd. is a biopharmaceutical company specializing in the development of innovative, first-in-class drugs for rare and intractable diseases. The company's clinical-stage pipeline focuses on addressing unmet medical needs in ophthalmology and oncology. Key development programs include RGN-259, a therapeutic agent for Dry Eye Disease and Neurotrophic Keratopathy, and OKN-007 for the treatment of Glioblastoma Multiforme. Additionally, the company is advancing a Natural Killer (NK) cell therapy through late-stage clinical trials to provide new therapeutic options for patients.

Recent filings

Filing Released Lang Actions
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from HLB Therapeutics regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. It details the number of shares issued, the conversion price, and the remaining balance of convertible bonds. This type of disclosure relates to changes in capital structure due to the conversion of debt into equity, which falls under the 'Share Issue/Capital Change' category.
2023-02-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details the change in share ownership by a major shareholder (Nomad No. 1 Association and its special related parties) in HLB Therapeutics. This document type is specifically used to notify the market and regulators of significant changes in shareholding levels, which falls under the 'Major Shareholding Notification' category.
2023-01-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the change in major shareholding status, including the reporting entity, special related parties, and the purpose of holding (influencing management). This corresponds to the 'Major Shareholding Notification' category.
2023-01-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding status of HLB Co., Ltd. in HLB Therapeutics Co., Ltd. following a change in the largest shareholder and a third-party capital increase. This is a standard regulatory filing for insider/major shareholder ownership reporting, which falls under the 'Director's Dealing' (DIRS) category as it tracks significant share ownership changes by major stakeholders.
2023-01-19 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Capital Increase' (유상증자결정) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange). It details the issuance of new shares, the purpose of the funds, and the third-party allocation details. This falls under the category of share issuance and capital structure changes.
2023-01-18 Korean
전환청구권행사(제14회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from HLB Therapeutics regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. This involves the issuance of new shares resulting from the conversion of debt into equity, which directly impacts the company's capital structure. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2023-01-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.